Jun Feng Wang
Direktor/Vorstandsmitglied bei SHENZHEN COLIBRI TECHNOLOGIES CO., LTD.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Kun Meng | M | 61 |
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 18 Jahre |
| Zhao Yi Wang | M | 65 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 18 Jahre |
| Chong Fei He | M | 55 | 16 Jahre | |
| Chi Shao | M | 38 | 8 Jahre | |
| Larry Zhang | M | - |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| Shao Ming Liu | M | 67 | 23 Jahre | |
| Hong Kuan Li | M | 51 | 9 Jahre | |
| Hong Ye | F | 50 | 9 Jahre | |
| Qi Chuan Lu | M | 42 |
Yeasen Biotechnology (Shanghai) Co., Ltd.
 Yeasen Biotechnology (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Yeasen Biotechnology (Shanghai) Co., Ltd. engages in the research, development, production, and sales of molecular, protein, and cell biological reagents. Its products are used in life science research, diagnosis and testing, biomedicine, and other fields. The company was founded by Wei Hua, Huang on January 9, 2014 and is headquartered in Shanghai, China. | 3 Jahre |
| Xiu Jiao Wu | F | 54 | 8 Jahre | |
| Wei Hua Huang | M | 45 |
Yeasen Biotechnology (Shanghai) Co., Ltd.
Yeasen Biotechnology (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Yeasen Biotechnology (Shanghai) Co., Ltd. engages in the research, development, production, and sales of molecular, protein, and cell biological reagents. Its products are used in life science research, diagnosis and testing, biomedicine, and other fields. The company was founded by Wei Hua, Huang on January 9, 2014 and is headquartered in Shanghai, China. | 10 Jahre |
| Dong Liang Song | M | 42 |
Yeasen Biotechnology (Shanghai) Co., Ltd.
Yeasen Biotechnology (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Yeasen Biotechnology (Shanghai) Co., Ltd. engages in the research, development, production, and sales of molecular, protein, and cell biological reagents. Its products are used in life science research, diagnosis and testing, biomedicine, and other fields. The company was founded by Wei Hua, Huang on January 9, 2014 and is headquartered in Shanghai, China. | 8 Jahre |
| Yun Zhong Hu | M | 49 | 9 Jahre | |
| Mei Hua Huo | M | 35 |
Yeasen Biotechnology (Shanghai) Co., Ltd.
Yeasen Biotechnology (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Yeasen Biotechnology (Shanghai) Co., Ltd. engages in the research, development, production, and sales of molecular, protein, and cell biological reagents. Its products are used in life science research, diagnosis and testing, biomedicine, and other fields. The company was founded by Wei Hua, Huang on January 9, 2014 and is headquartered in Shanghai, China. | 3 Jahre |
| Heng Lin | M | 44 | 13 Jahre | |
| Jie Jiao | F | 43 | 14 Jahre | |
| Guang Zhong Cao | M | 56 | 5 Jahre | |
| Robert Kamen | M | 79 |
Harbour BioMed (Shanghai) Co., Ltd.
 Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | 8 Jahre |
| Pei Wei | M | 43 | 5 Jahre | |
| Ji Feng Shi | M | 50 | 7 Jahre | |
| Chen Du | M | 64 | 4 Jahre | |
| Cheng Hao Zhu | M | 48 | 9 Jahre | |
| Bao Ping Wang | M | 63 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 6 Jahre |
| Yong Peng | M | 62 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 6 Jahre |
| Ye Yan | F | 66 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 Jahre |
| Lu Nan Chen | M | 60 | 2 Jahre | |
| Jing Jing Wang | M | 40 |
Yeasen Biotechnology (Shanghai) Co., Ltd.
Yeasen Biotechnology (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Yeasen Biotechnology (Shanghai) Co., Ltd. engages in the research, development, production, and sales of molecular, protein, and cell biological reagents. Its products are used in life science research, diagnosis and testing, biomedicine, and other fields. The company was founded by Wei Hua, Huang on January 9, 2014 and is headquartered in Shanghai, China. | 3 Jahre |
| Xu Tian | F | 64 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 Jahre |
| Jian Xun Liu | M | 69 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 Jahre |
| Lei Zhu | F | 44 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 10 Jahre |
| Shu Xue Wang | M | 48 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 9 Jahre |
| Can Zhou | M | 39 | 3 Jahre | |
| Yi Ping Rong | M | 47 |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | 8 Jahre |
| Ai Dong Wang | M | 61 | 3 Jahre | |
| Chao He Yang | M | 60 | 3 Jahre | |
| Zhen Cao | M | 38 |
Yeasen Biotechnology (Shanghai) Co., Ltd.
Yeasen Biotechnology (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Yeasen Biotechnology (Shanghai) Co., Ltd. engages in the research, development, production, and sales of molecular, protein, and cell biological reagents. Its products are used in life science research, diagnosis and testing, biomedicine, and other fields. The company was founded by Wei Hua, Huang on January 9, 2014 and is headquartered in Shanghai, China. | 9 Jahre |
| Albert Collinson | M | 66 | 1 Jahre | |
| Yan Cui | F | 40 | 13 Jahre | |
| Yan Min Tang | F | 51 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 Jahre |
| Jun Yu | F | 52 |
Yeasen Biotechnology (Shanghai) Co., Ltd.
Yeasen Biotechnology (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Yeasen Biotechnology (Shanghai) Co., Ltd. engages in the research, development, production, and sales of molecular, protein, and cell biological reagents. Its products are used in life science research, diagnosis and testing, biomedicine, and other fields. The company was founded by Wei Hua, Huang on January 9, 2014 and is headquartered in Shanghai, China. | 3 Jahre |
| Jian Wei Zhu | M | 69 | 3 Jahre | |
| Ka Chi Yau | M | 66 | 3 Jahre | |
| Man Li Su | M | 54 | 3 Jahre | |
| Dan Dan Li | F | 53 | 12 Jahre | |
| Dong Hua Wen | M | 51 |
Yeasen Biotechnology (Shanghai) Co., Ltd.
Yeasen Biotechnology (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Yeasen Biotechnology (Shanghai) Co., Ltd. engages in the research, development, production, and sales of molecular, protein, and cell biological reagents. Its products are used in life science research, diagnosis and testing, biomedicine, and other fields. The company was founded by Wei Hua, Huang on January 9, 2014 and is headquartered in Shanghai, China. | 3 Jahre |
| Xiao Ping Ye | M | 61 | 4 Jahre | |
| De Sheng Zhou | M | 53 | 16 Jahre | |
| Jing Song Wang | M | 60 |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | - |
| Jun Xie | M | 55 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 Jahre |
| Fu Li Zheng | F | 51 | 5 Jahre | |
| Jian Guang Li | M | 59 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| Hui Fang Shi | F | 43 | 9 Jahre | |
| Weihao Xu | M | 42 | 3 Jahre | |
| Yu Min Qiu | M | 51 |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | 8 Jahre |
| Shao Dong Liu | M | 58 | 23 Jahre | |
| Hui Ji Tan | F | 49 | 23 Jahre | |
| Jun Fei Feng | M | 41 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 Jahre |
| Lian Qin Li | F | 35 |
Yeasen Biotechnology (Shanghai) Co., Ltd.
Yeasen Biotechnology (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Yeasen Biotechnology (Shanghai) Co., Ltd. engages in the research, development, production, and sales of molecular, protein, and cell biological reagents. Its products are used in life science research, diagnosis and testing, biomedicine, and other fields. The company was founded by Wei Hua, Huang on January 9, 2014 and is headquartered in Shanghai, China. | 5 Jahre |
| Wang Haibo Edward Wang | M | - | - | |
| Guang Yong Yang | M | 57 | 18 Jahre | |
| Kun Guo | F | 47 | 5 Jahre | |
| Dong Lü | M | 40 | 8 Jahre | |
| Lan Kang | M | - | - | |
| Wing Yu Leung | F | 53 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| Robert Eisenman | M | - |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| Ke Min Li | F | 30 |
Yeasen Biotechnology (Shanghai) Co., Ltd.
Yeasen Biotechnology (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Yeasen Biotechnology (Shanghai) Co., Ltd. engages in the research, development, production, and sales of molecular, protein, and cell biological reagents. Its products are used in life science research, diagnosis and testing, biomedicine, and other fields. The company was founded by Wei Hua, Huang on January 9, 2014 and is headquartered in Shanghai, China. | 3 Jahre |
| Xing Meng | F | 34 |
Yeasen Biotechnology (Shanghai) Co., Ltd.
Yeasen Biotechnology (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Yeasen Biotechnology (Shanghai) Co., Ltd. engages in the research, development, production, and sales of molecular, protein, and cell biological reagents. Its products are used in life science research, diagnosis and testing, biomedicine, and other fields. The company was founded by Wei Hua, Huang on January 9, 2014 and is headquartered in Shanghai, China. | 3 Jahre |
| Humphrey Gardner | M | 60 | 2 Jahre | |
| Wei Wei Chen | F | - |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | - |
| Daqing Cai | M | 59 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| Chen Yang Wei | M | 51 |
PBC School of Finance Tsinghua University
| 5 Jahre |
| Lei Chen | M | 45 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| Meng Jun Xue | M | 53 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| San Guo Zhu | M | 74 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 8 Jahre |
| Lok Yee Chan | F | 35 | 6 Jahre | |
| Li Li Ma | M | 44 | 9 Jahre | |
| Li Ming Pan | M | 63 | 23 Jahre | |
| Zhen Lun Lin | M | 67 | 12 Jahre | |
| Run Lu Deng | M | 64 | 16 Jahre | |
| Shi Xian Yang | M | 41 |
Yeasen Biotechnology (Shanghai) Co., Ltd.
Yeasen Biotechnology (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Yeasen Biotechnology (Shanghai) Co., Ltd. engages in the research, development, production, and sales of molecular, protein, and cell biological reagents. Its products are used in life science research, diagnosis and testing, biomedicine, and other fields. The company was founded by Wei Hua, Huang on January 9, 2014 and is headquartered in Shanghai, China. | 4 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Cheuk Him Ng | M | 49 | 4 Jahre | |
| Rui Xia Liu | M | 42 | 15 Jahre | |
| Shi Hai Wang | M | 48 | 6 Jahre | |
| Dong Wang | M | 51 | - | |
| Qin Wang | M | 58 |
PBC School of Finance Tsinghua University
| 28 Jahre |
| Xiao Xiang Chen | M | 54 | 6 Jahre | |
| Mai Jing Liao | M | 54 | 5 Jahre | |
| Munir Shahin | M | - |
McMaster University
| 5 Jahre |
| Chang Bo Huang | M | 51 | 3 Jahre | |
| Li Ping Zhang | F | 50 | - | |
| Chen Guang Liu | M | 62 | 6 Jahre | |
| Wen Jing Liu | F | 36 | - | |
| James Orlando | M | - |
McMaster University
| 5 Jahre |
| Zhen Po Wang | M | 48 | - | |
| Zhi Yong Gao | M | 61 | 5 Jahre | |
| Zhao Lin Wang | M | 54 | - | |
| Rami Rahal | M | - |
McMaster University
| 4 Jahre |
| Todd D'Amico | M | - |
McMaster University
| 6 Jahre |
| Shah Altamash Khan | M | - |
McMaster University
| 7 Jahre |
| Wen Xu Yang | M | 35 | 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| China | 85 | 85,00% |
| Cayman Islands | 9 | 9,00% |
| Kanada | 5 | 5,00% |
| Hong Kong | 2 | 2,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Jun Feng Wang
- Persönliches Netzwerk
